Islamic fasting and multiple sclerosis

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Jahromi, Soodeh R ^a   Sahraian, Mohammad A ^a   Ashtari, Fereshteh ^b   Ayromlou, Hormoz ^c   Etemadifar, Massoud ^b   Ghaffarpour, Majid ^d   Mohammadianinejad, Ehsan ^e   Nafissi, Shahriar ^f   Nickseresht, Alireza ^g   Shaygannejad, Vahid ^b   Togha, Mansoreh ^a   Torabi, Hamid R ^h   Ziaie, Shadi ⁱ  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h Jam General Hospital   (Iran)

ⁱ SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calorie restriction; Multiple sclerosis; Ramadan fasting

Indexed keywords

ANTICONVULSIVE AGENT; GLUCOCORTICOID; INTERLEUKIN 6; SPASMOLYTIC AGENT;

ANTICONVULSANT THERAPY; ARTICLE; BALANCE DISORDER; CALORIC RESTRICTION; COGNITIVE DEFECT; DEMYELINATION; DIET RESTRICTION; DISEASE SEVERITY; DIZZINESS; EXPANDED DISABILITY STATUS SCALE; FATIGUE; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; RELIGION; SPASTICITY; VISUAL DISORDER; WEAKNESS;

ANIMALS; DISEASE PROGRESSION; FASTING; FATIGUE; HUMANS; MULTIPLE SCLEROSIS;

EID: 84898866381     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-56     Document Type: Article

References (47)

1. Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S. Recommendations for management of diabetes during Ramadan update 2010. Diabetes Care 1895-1902, 2010:33.
2. Azizi F. Islamic fasting and health. Ann Nutr Metab 2010, 56:273-282.
3. Beshyah SA, Fathalla W, Saleh A, Al Kaddour A, Noshi M, Al Hateethi H, Al-Saadawi N, Elsiesi H, Amir N, Almarzouqi M. Mini-symposium: ramadan fasting and The Medical Patient: an overview for clinicians. Ibnosina J Med Biomed Sci 2010, 2.
4. Buchanan R, Huang C. Health-related quality of life among informal caregivers assisting people with multiple sclerosis. Disability Rehabil 2011, 33:113-121.
5. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001, 81:263-281.
6. Esquifino A, Cano P, Jimenez V, Cutrera R, Cardinali D. Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem 2004, 60:245-252.
7. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009, 59:293-315.
8. Noh HS, Kim DW, Kang SS, Cho GJ, Choi WS. Ketogenic diet prevents clusterin accumulation induced by kainic acid in the hippocampus of male ICR mice. Brain Res 2005, 1042:114-118.
9. Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, Shin HS, Kang SS, Cho GJ, Choi WS. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J Neurosci Res 1829-1836, 2006:84.
10. Noh HS, Hah YS, Nilufar R, Han J, Bong JH, Kang SS, Cho GJ, Choi WS. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res 2006, 83:702-709.
11. Opalach K, Rangaraju S, Madorsky I, Leeuwenburgh C, Notterpek L. Lifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves. Rejuvenat Res 2010, 13:65-74.
12. Cheng CM, Hicks K, Wang J, Eagles DA, Bondy CA. Caloric restriction augments brain glutamic acid decarboxylase-65 and-67 expression. J Neurosci Res 2004, 77:270-276.
13. Swerdlow RH. Treating neurodegeneration by modifying mitochondria: potential solutions to a " complex" problem. Antioxidants redox signal 2007, 9:1591-1604.
14. Guarente L. Calorie restriction and sirtuins revisited. Genes Dev 2072-2085, 2013:27.
15. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001, 79:376-384.
16. Rogozina OP, Bonorden MJ, Seppanen CN, Grande JP, Cleary MP. Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prevent Res 2011, 4:568-581.
17. Esquifino AI, Cano P, Jimenez-Ortega V, Fernández-Mateos MP, Cardinali DP. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation 2007, 4:6.
18. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J leukocyte Biol 2008, 84:940-948.
19. Myhr K, Mellgren S. Corticosteroids in the treatment of multiple sclerosis. Acta Neurol Scand 2009, 120:73-80.
20. Bolton C, O'Neill J, Allen S, Baker D. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int Arch Allergy Immunol 1997, 114:74-80.
21. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009, 10:1252-1259.
22. Ahmed T, Das SK, Golden JK, Saltzman E, Roberts SB, Meydani SN. Calorie Restriction Enhances T-Cell-Mediated Immune Response in Adult Overweight Men and Women. J Gerontol A Biol Sci Med Sci 2009, 64:1107-1113.
23. Pali A, Paszthy B. Changes of the immune functions in patients with eating disorders]. Ideggyógyászati Szemle 2008, 61:381.
24. Fontana L, Coleman R, Holloszy J, Weindruch R. Calorie restriction in non-human and human primates. Handbook Biol Aging 2010,
25. Fraser D, Thoen J, Reseland J, Førre T, Kjeldsen-Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 1999, 18:394-401.
26. Latifynia A, Vojgani M, Gharagozlou M, Sharifian R. Neutrophil function (innate immunity) during Ramadan. J Ayub Med College, Abbottabad: JAMC 2008, 21:111-115.
27. El-Dayem SMA, Zyton HAH. The Effect of Ramadan Fasting on Multiple Sclerosis. Egyptian J Neurol Psychiatry Neurosurg 2012, 49:341-345.
28. Saadatnia M, Etemadifar M, Fatehi F, Ashtari F, Shaygannejad V, Chitsaz A, Maghzi AH. Short-term effects of prolonged fasting on multiple sclerosis. Eur Neurol 2009, 61:230-232.
29. Chtourou H, Hammouda O, Chaouachi A, Chamari K, Souissi N. The effect of time-of-day and Ramadan fasting on anaerobic performances. Int J Sports Med 2012, 33:142.
30. Schmahl F, Metzler B. The health risks of occupational stress in islamic industrial workers during the Ramadan fasting period. Polish J Occupational Med Environ Health 1991, 4:219.
31. Assadi M, Akrami A, Beikzadeh F, Seyedabadi M, Nabipour I, Larijani B, Afarid M, Seidali E. Impact of Ramadan fasting on intraocular pressure, visual acuity and refractive errors. Singapore Med J 2011, 52:263-266.
32. Souissi N, Chtourou H, Zouita A, Dziri C, Souissi N. Effects of Ramadan intermittent fasting on postural control in judo athletes. Biol Rhythm Res 2013, 44:237-244.
33. Chennaoui M, Desgorces F, Drogou C, Boudjemaa B, Tomaszewski A, Depiesse F, Burnat P, Chalabi H, Gomez-Merino D. Effects of Ramadan fasting on physical performance and metabolic, hormonal, and inflammatory parameters in middle-distance runners. Appl Physiol Nutr Metab 2009, 34:587-594.
34. Chtourou H, Hammouda O, Souissi H, Chamari K, Chaouachi A, Souissi N. The effect of Ramadan fasting on physical performances, mood state and perceived exertion in young footballers. Asian J Sports Med 2011, 2:177-185.
35. Tian H-H, Aziz A-R, Png W, Wahid M, Yeo D, Png A-L. Effects of fasting during Ramadan month on cognitive function in Muslim athletes. Asian J Sports Med 2011, 2:145-153.
36. Aadil N, Fassi-Fihri A, Houti I, Benaji B, Ouhakki M, Kotbi S, Diquet B, Hakkou F. Influence of Ramadan on the pharmacokinetics of a single oral dose of valproic acid administered at two different times. Methods Find Exp Clin Pharmacol 2000, 22:109-114.
37. Singh BN. Effects of food on clinical pharmacokinetics. Clin Pharmacokinetics 1999, 37:213-255.
38. Charman WN, Porter CJ, Mithani S, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharmaceutical Sci 1997, 86:269-282.
39. Berry D, Millington C. Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Ther Drug Monit 2005, 27:451-456.
40. Shah J, Wesnes KA, Kovelesky RA, Henney IIIHR. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther 2006, 28:1308-1317.
41. Gidal BE, Maly MM, Kowalski JW, Rutecki PA, Pitterle ME, Cook DE. Gabapentin absorption: effect of mixing with foods of varying macronutrient composition. Ann Pharmacother 1998, 32:405-409.
42. Gomceli YB, Kutlu G, Cavdar L, Inan LE. Does the seizure frequency increase in Ramadan?. Seizure 2008, 17:671-676.
43. Messina S, Patti F. The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment. Expert Opin Metab Toxicol 2013, 9:1349-1359.
44. Sturzebecher S, Maibauer R, Heuner A, Beckmann K, Aufdembrinke B. Pharmacodynamic comparison of single doses of IFN-beta 1a and IFN-beta 1b in healthy volunteers. J Interferon Cytokine Res 1999, 19:1257-1264.
45. Singh BN, Malhotra BK. Effects of food on the clinical pharmacokinetics of anticancer agents. Clin Pharmacokinetics 2004, 43:1127-1156.
46. De Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinetics 2005, 44:1135-1164.
47. Maughan RJ, Zerguini Y, Chalabi H, Dvorak J. Achieving optimum sports performance during Ramadan: some practical recommendations. Clin Pharmacokinetics 2012, 30:S109-S117.